ArticleHeart and vessels2012
Diffuse in-stent restenosis of CYPHER® stent due to hypersensitivity reaction confirmed by pathohistological findings.
Article in Heart and vessels, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Pathological analysis of a case with peri-stent contrast staining after BMS implantation.Journal of cardiology cases · 2016Article
- Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.Heart and vessels · 2016Article
- Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.Heart and vessels · 2015Article
- Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy.Heart and vessels · 2015Article
- Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation.Heart and vessels · 2015Article
- Bioresorbable scaffolds for the treatment of in-stent restenosis.Heart and vessels · 2015Article
- Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia.Heart and vessels · 2014Article
- The late-phase inflammatory response after drug-eluting stent implantation.Heart and vessels · 2014Observational
- Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation.Heart and vessels · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of drug-eluting stents (DES) reduces the risk of repeat revascularization without increase of death and myocardial infarction compared to standard bare metal stents. However, in-stent restenosis (ISR) after DES implantation still occurs. Here, we report a rare case with a diffuse ISR after CYPHER® stent implantation because of chronic inflammation and hypersensitivity reactions, confirmed by pathohistological findings.
Indexed as
Identifiers
21526419What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.